Back
Merck & Co Inc (MRK)
PharmaceuticalsMRK · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$152.55
+2.39%Weekly undervalued picks (like MRK)
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$7.28
ROE
18.9%
Gross margin
76.7%
Debt/Equity
1.07x
Revenue growth
4.9%
Merck & Co Inc — company intelligence
Earnings surprises
Q2 2026$-0.13 vs $-0.27 est+52.3%
Q1 2026$-1.28 vs $-1.52 est+16.0%
Q4 2025$2.09 vs $2.03 est+3.0%
Q3 2025$2.68 vs $2.37 est+13.1%
Analyst consensus · 36 analysts
25 Buy11 Hold0 Sell
Updated Aug 22, 2026
Insider activity · 90 days
15 buys11 sellsnet -134,027 shares
Guindo ChirfiSell 10,000 · Aug 13, 2026
Zachary Jenniferother 41,494 · Aug 12, 2026
Zachary JenniferSell 80,315 · Aug 12, 2026
Recent SEC filings
4 — Insider transaction reportAug 13, 2026
4 — Insider transaction reportAug 13, 2026
4 — Insider transaction reportAug 12, 2026
Latest news
Morgan Stanley Upgrades Merck (MRK) — Fintel · 5d ago
RBC Capital Downgrades Merck (MRK) — Fintel · 5d ago
XBI: Biotech's Breakthrough Moment Happend This Week (Upgrade) — SeekingAlpha · 5d ago
QUICK SPARK: Moderna Stock Drops 25%, Eyes Worst Day in Company's History — Benzinga · 5d ago
BMO Capital Maintains Outperform on Merck & Co, Raises Price Target to $170 — Benzinga · 5d ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks (like MRK)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.